📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ArriVent BioPharma

1.1 - Company Overview

ArriVent BioPharma Logo

ArriVent BioPharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical product development to cure presently untreatable cancer.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ArriVent BioPharma

ProCure Logo

ProCure

HQ: United States Website
  • Description: Provider of a network of proton therapy centers in the United States, offering proton therapy including pencil beam scanning; physician case evaluations; initial consultation and planning; treatment sessions typically 5 days a week for 4–7 weeks; and regular radiation oncologist check-ins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProCure company profile →
Mevion Medical Systems Logo

Mevion Medical Systems

HQ: United States Website
  • Description: Provider of innovative, safe, and effective radiation therapy solutions for the treatment of cancer, pioneering modern proton therapy systems and transforming advances in medical technology and science into practical clinical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mevion Medical Systems company profile →
Exousia Pro Logo

Exousia Pro

HQ: United States Website
  • Description: Provider of exosome-based therapeutics for cancer and other diseases, with research in plant-derived exosomes and integration of AI to support development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exousia Pro company profile →
Arius Research Logo

Arius Research

HQ: Canada Website
  • Description: Provider of biotechnology solutions centered on the discovery and development of antibody therapeutics, primarily targeting breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia, and melanoma, leveraging its FunctionFIRST platform to identify monoclonal antibodies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arius Research company profile →
Avila Therapeutics Logo

Avila Therapeutics

HQ: United States Website
  • Description: Provider of covalent drugs for viral infections, cancers, and autoimmune diseases, designing and developing targeted small-molecule therapies including AVL-181, a hepatitis C virus protease inhibitor; partnered with Sanofi-Aventis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avila Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ArriVent BioPharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ArriVent BioPharma

2.2 - Growth funds investing in similar companies to ArriVent BioPharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ArriVent BioPharma

4.2 - Public trading comparable groups for ArriVent BioPharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ArriVent BioPharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ArriVent BioPharma

What does ArriVent BioPharma do?

ArriVent BioPharma is a provider of pharmaceutical product development to cure presently untreatable cancer.

Who are ArriVent BioPharma's competitors?

ArriVent BioPharma's competitors and similar companies include ProCure, Mevion Medical Systems, Exousia Pro, Arius Research, and Avila Therapeutics.

Where is ArriVent BioPharma headquartered?

ArriVent BioPharma is headquartered in United States.

How many employees does ArriVent BioPharma have?

ArriVent BioPharma has 1,000 employees 🔒.

When was ArriVent BioPharma founded?

ArriVent BioPharma was founded in 2010 🔒.

What sector and industry vertical is ArriVent BioPharma in?

ArriVent BioPharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ArriVent BioPharma

Who are the top strategic acquirers in ArriVent BioPharma's sector and industry

Top strategic M&A buyers and acquirers in ArriVent BioPharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ArriVent BioPharma?

Top strategic M&A buyers groups and sectors for ArriVent BioPharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ArriVent BioPharma's sector and industry vertical

Which are the top PE firms investing in ArriVent BioPharma's sector and industry vertical?

Top PE firms investing in ArriVent BioPharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ArriVent BioPharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ArriVent BioPharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ArriVent BioPharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ArriVent BioPharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ArriVent BioPharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ArriVent BioPharma?

The key public trading comparables and valuation benchmarks for ArriVent BioPharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ArriVent BioPharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ArriVent BioPharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ArriVent BioPharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ArriVent BioPharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ArriVent BioPharma's' sector and industry vertical?

Access recent funding rounds and capital raises in ArriVent BioPharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ArriVent BioPharma